MediWound (MDWD) Tops Q4 EPS by 4c, provides guidance

MediWound (NASDAQ: MDWD) reported Q4 EPS of ($0.19), $0.04 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.32 million.

GUIDANCE:

MediWound sees FY2024 revenue of $24 million, versus the consensus of $23.787 million.

For earnings history and earnings-related data on MediWound (MDWD) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Jefferies Upgrades TC Energy (TRP:CN) (TRP) to Buy
• Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK436 at Morgan Stanley